Cardiology Research Group
101 – 110 of 165
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Replik om subventionering av läkemedel mot högt blodtryck: Problemet är en enastående underbehandling av hypertoni.
(
- Contribution to journal › Article
-
Mark
Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg.
(
- Contribution to journal › Article
-
Mark
Self-rated health and classical risk factors for coronary heart disease predict development of erectile dysfunction 25 years later.
(
- Contribution to journal › Article
-
Mark
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
(
- Contribution to journal › Article
-
Mark
Severe dyspnoea on light exercise at high altitude: Unusual presentation of Ebstein's anomaly.
(
- Contribution to journal › Article
-
Mark
Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: Findings from the EUROASPIRE II survey
(
- Contribution to journal › Article
-
Mark
Gender Differences in Predictors of Heart Failure Morbidity and Mortality in an Urban Swedish Population: The Malmo Preventive Project
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2007
-
Mark
Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.
(
- Contribution to journal › Article
-
Mark
Coronary flow velocity reserve reduction is comparable in patients with erectile dysfunction and in patients with impaired fasting glucose or well-regulated diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Impact of neurohormonal blockade on association between body mass index and mortality.
(
- Contribution to journal › Article